APOL1 Localization in Normal Kidney and Nondiabetic Kidney Disease
Authors:
- John F. O'TooleJOJohn F. O'Toole
- Martha KonieczkowskiMKMartha Konieczkowski
- Santhi GanesanSGSanthi Ganesan
- Leslie A. BruggemanLBLeslie A. Bruggeman
- John R. SedorJSJohn R. Sedor
Open Access
- 1 November 2011
- journal article
- Published by Wolters Kluwer Health in Journal of the American Society of Nephrology
- Vol. 22 (11) , 2119-2128
Abstract
In patients of African ancestry, genetic variants in APOL1, which encodes apolipoprotein L1, associate with the nondiabetic kidney diseases, focal segmental glomerulosclerosis (FSGS), HIV-associated nephropathy (HIVAN), and hypertensive nephropathy. Understanding the renal localization of APOL1 may provide clues that will ultimately help elucidate the mechanisms by which APOL1 variants promote nephropathy. Here, we used immunohistology to examine APOL1 localization in normal human kidney sections and in biopsies demonstrating either FSGS (n = 8) or HIVAN (n = 2). Within normal glomeruli, APOL1 only localized to podocytes. Compared with normal glomeruli, fewer cells stained for APOL1 in FSGS and HIVAN glomeruli, even when expression of the podocyte markers GLEPP1 and synaptopodin appeared normal. APOL1 localized to proximal tubular epithelia in normal kidneys, FSGS, and HIVAN. We detected APOL1 in the arteriolar endothelium of normal and diseased kidney sections. Unexpectedly, in both FSGS and HIVAN but not normal kidneys, the media of medium artery and arterioles contained a subset of α-smooth muscle actin-positive cells that stained for APOL1. Comparing the renal distribution of APOL1 in nondiabetic kidney disease to normal kidney suggests that a previously unrecognized arteriopathy may contribute to disease pathogenesis in patients of African ancestry.Keywords
This publication has 34 references indexed in Scilit:
- A map of human genome variation from population-scale sequencingNature, 2010
- Association of Trypanolytic ApoL1 Variants with Kidney Disease in African AmericansScience, 2010
- Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 geneHuman Genetics, 2010
- Podocyte Injury Induces Nuclear Translocation of WTIP via Microtubule-dependent TransportJournal of Biological Chemistry, 2010
- Genetics of Focal Segmental Glomerulosclerosis and Human Immunodeficiency Virus–Associated Collapsing Glomerulopathy: The Role of MYH9 Genetic VariationSeminars in Nephrology, 2010
- Dense mapping of MYH9 localizes the strongest kidney disease associations to the region of introns 13 to 15Human Molecular Genetics, 2010
- The apolipoprotein L family of programmed cell death and immunity genes rapidly evolved in primates at discrete sites of host–pathogen interactionsGenome Research, 2009
- MYH9 is associated with nondiabetic end-stage renal disease in African AmericansNature Genetics, 2008
- MYH9 is a major-effect risk gene for focal segmental glomerulosclerosisNature Genetics, 2008
- Apolipoprotein L1, a Novel Bcl-2 Homology Domain 3-only Lipid-binding Protein, Induces Autophagic Cell DeathJournal of Biological Chemistry, 2008